Journal of Oncology / 2010 / Article / Fig 4

Research Article

Architectural Heterogeneity in Tumors Caused by Differentiation Alters Intratumoral Drug Distribution and Affects Therapeutic Synergy of Antiangiogenic Organoselenium Compound

Figure 4

Change in relative vascular permeability and vascular volume as a result of treatment with MSC in H69 (a), A549 (b), A253 (c), PDSCC (d), and WDSCC (e) tumors as assessed by DCE-MRI.
396286.fig.004a
(a) H69
396286.fig.004b
(b) A549
396286.fig.004c
(c) A253
396286.fig.004d
(d) Patient SCC (Poorly-diff)
396286.fig.004e
(e) Patient SCC (Well-diff)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.